Myeloma: Prognosis

Key points

• B2-microglobulin is a useful prognostic marker in myeloma — raised levels imply a poorer prognosis
• Low serum albumin is also associated with a poorer prognosis
• The International Staging System combines B2-microglobulin and albumin to stratify patients by median survival